1HolmR,SkomedalH,HelandA,etal.Immunohistochemicalanalysisofp53proteinoverexpressioninnormal,premalignantandmalignanttisuesofthecervixuteri[].The Journal of Pathology.1993
2Avall-LundqvistEH,SilfverswardC,AspenbladU,etal.Theimpactoftumorangiogenesis,p53overexpressionandproliferativeactivity(MIB-1)onsurvivalinsquamouscervicalcarcinoma犤J犦[].European Journal of Cancer.1997
3PolacarzSV,DarneJ,SheridanEG,etal.Endocervicalcarcinomaandprecursorlesions:C-mycex-pressionandthedemonstrationoffieldchanges[].Journal of Clinical Pathology.1991
4Hale RJ,Buckley CH,Fox H,et al.Prognostic value of c-erbB2 expression in uterine cervical carcinoma[].Journal of Clinical Pathology.1992
6HudziakRM,SchlessingerJ,UurichA ,etal.IncreasedexpressionoftheputationgrowthfactorreceptorP185HER2causestransforma tionandtumorigenesisofNIH -ST3cell[].Proceedings of the National Academy of Sciences of the United States of America.1987
1Gendes J,Lemke H,Baish H,et al.Cell cycle analysis of a cell proliferation associated human nuclear antigen defined by the monoclonal antibody Ki-56[J].J Immunol,1984,133(4):1710-1715.
2Schluter C,Duchrow M,Woblenberg C,et al.The cell proliferation associated antigen of antibody Ki-56:a very large ubiqutions nuclear protein with numerous repeated elements representing a new kind of cell cycle maintaining proteins[J].J Cell Bio,1993,23:5131.
3Kruse AJ,Baak JPA,Janssen EA,et al.Ki6predicts progression in early CIN:Validation of a multivariate progression-risk model[J].Cell Oncol,2004,26:13-20.
4Drobnjak M,Latres E,Pollack D,et al.Prognostic implications of P53 nuclear overexpression and high proliferation index of Ki -67 in adult soft-tissue sarcomas[J].J Natl Cancer Inst,1994,86(7):549-554
5Fonatsch C,Duchrow M,Rieder H,et al.Assignment of the human Ki-67 gene(MKI67) to 10q25-qter[J].Genomics,1991,11(2):476-477
6Tangjitgamol S,Ramirez PT,Sun CC,et al.Expression of HER-2/neu,epidermal growth factor receptor,vascular endothelial growth factor,cyclooxygenase-2,estrogen receptor,and progesterone receptor in small cell and large cell neuroendocrine carcinoma of the uterine cervix:a clinicopathologic and prognostic study[J].Int J Gynecol Cancer,2005,15:646-656
7Seliger B,Rongcun Y,Atkins D,et al.HER2/neu is expressed in human renal cell carcinoma at hetero-geneous levels independently of tumor grading and can be recognized by HLA-Az.1-restricted cytotoxic T lymphocytes[J].Int J Cancer,2000,87:349-359
8Lee TK,Poon RT,Yuen AP,et al.Regulation of angiogenesis by Id-1 through hypoxia-inducible factor-1 {alpha}-mediated vascular endothelial growth factor up-regulation in hepatocellular carcinoma[J].Clin Cancer Res,2006,12:6910-6919
9Chavez-Blanco A,Perez-Sanchez V,Gonzalez-Fierro a,et al.HER-2 expression in cervical cancer as a potential therapeutic target[J].BMC Cancer,2004,1:59-63
10Rasila KK,Burger RA,Smith H,et al.Angiogenesis in gynecological oncology-mechanism of tumor progression and therapeutic targets[J].Int J Gynecol Cancer,2005,15:710-726
